Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sitagliptin in Combination Oral Agent Therapy for Type 2 Diabetes

NCT00686634 is registered in ClinicalTrials.gov with Charles Drew University of Medicine and Science as lead sponsor.

NCT NCT00686634
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00686634 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sitagliptin in Combination Oral Agent Therapy for Type 2 Diabetes
Lead sponsor
Charles Drew University of Medicine and Science
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2008
Completion date
March 31, 2010
Enrollment
108 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus